VYNE THERAPEUTICS INC's ticker is VYNE and the CUSIP is 92941V209. A total of 46 filers reported holding VYNE THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $3,503 | -41.6% | 23,347 | -1.3% | 0.00% | – |
Q3 2022 | $6,000 | -62.5% | 23,647 | -43.8% | 0.00% | – |
Q2 2022 | $16,000 | -44.8% | 42,109 | -6.2% | 0.00% | – |
Q1 2022 | $29,000 | -77.9% | 44,876 | -64.8% | 0.00% | – |
Q4 2021 | $131,000 | -51.7% | 127,664 | -34.4% | 0.00% | – |
Q3 2021 | $271,000 | -62.0% | 194,618 | -4.2% | 0.00% | – |
Q2 2021 | $713,000 | +176.4% | 203,075 | +438.6% | 0.00% | – |
Q1 2021 | $258,000 | – | 37,703 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
DSC Advisors, L.P. | 2,551,000 | $2,602,000 | 2.01% |
Perceptive Advisors | 4,356,044 | $4,444,000 | 0.03% |
GSA CAPITAL PARTNERS LLP | 217,747 | $222,000 | 0.03% |
Virtu Financial LLC | 175,278 | $179,000 | 0.02% |
XTX Topco Ltd | 17,053 | $17,000 | 0.01% |
SkyOak Wealth, LLC | 27,200 | $28,000 | 0.01% |
DELTEC ASSET MANAGEMENT LLC | 30,000 | $31,000 | 0.01% |
Tekla Capital Management LLC | 135,395 | $138,000 | 0.00% |
STALEY CAPITAL ADVISERS INC | 62,500 | $64,000 | 0.00% |
TWO SIGMA SECURITIES, LLC | 47,475 | $48,000 | 0.00% |